牛磺熊去氧胆酸通过调控TBC1D15改善线粒体自噬减轻氧糖剥夺心肌细胞损伤的机制

doi:10.3969/j.issn.1006-5725.2026.02.007

摘要/Abstract

摘要：

目的探讨牛磺熊去氧胆酸（TUDCA）通过特异性调控TBC1D15蛋白表达和定位，恢复线粒体自噬功能，从而减轻氧糖剥夺（OGD）诱导的心肌细胞损伤的作用机制。方法采用传代心肌细胞H9c2OGD模型，设置正常对照组、模型组及TUDCA低（20 μmol/L）、中（40 μmol/L）、高（80 μmol/L）剂量干预组。通过免疫荧光检测TBC1D15亚细胞定位与表达，YO-PRO-1/PI双染评估细胞凋亡/坏死，溶酶体染色检测溶酶体功能并使用HBAD-mcherry-EGFP-LC3检测细胞自噬活性，Western blot分析自噬相关蛋白Beclin-1、LC3-Ⅱ/Ⅰ、p62及凋亡蛋白Bcl-2的表达情况。结果与正常对照组相比，模型组TBC1D15表达显著降低且分布紊乱；经TUDCA干预后，TBC1D15 表达呈剂量依赖性恢复，高剂量组荧光强度接近正常对照组水平，且细胞膜定位明显增强。在自噬相关指标方面，TUDCA 中、高剂量组显著促进自噬活化，具体表现为LC3-Ⅱ/Ⅰ比值升高、p62 降解加速以及Beclin-1表达增加。细胞凋亡/坏死检测结果显示，模型组细胞凋亡/坏死显著增加，而 TUDCA 干预后，细胞凋亡/坏死情况明显改善，同时抗凋亡蛋白Bcl-2表达上调，且这种改善效果在高剂量组最为显著。结论 TUDCA通过剂量依赖性方式恢复TBC1D15蛋白的膜定位，进而激活线粒体自噬通路，最终协同抑制细胞凋亡/坏死。

关键词: 牛磺熊去氧胆酸, 线粒体自噬, TBC1D15, 氧糖剥夺, 心肌细胞损伤

Abstract:

Objective ? To elucidate the mechanism by which tauroursodeoxycholic acid （TUDCA） alleviates oxygen-glucose deprivation （OGD）-induced cardiomyocyte injury through specific regulation of TBC1D15 protein expression and subcellular localization to restore mitophagy function. Methods ? Primary cardiomyocytes were subjected to OGD and treated with TUDCA at low （20 μmol/L）， medium （40 μmol/L）， or high （80 μmol/L） doses. TBC1D15 subcellular localization and expression were assessed by immunofluorescence. Cell apoptosis/necrosis was evaluated using YO-PRO-1/PI double staining. Lysosome staining is used to detect lysosome function. Autophagy dual-labeling adenovirus HBAD-mcherry-EGFP-LC3 is used to detect the efficiency of autophagy flow.Western blot was performed to analyze autophagy-related proteins （Beclin-1， LC3-Ⅱ/Ⅰ， p62） and the anti-apoptotic protein Bcl-2. Results Compared with the normal control group， the model group showed a significant decrease in TBC1D15 expression and disordered distribution. After TUDCA intervention， the expression of TBC1D15 was restored in a dose-dependent manner. In the high-dose group， the fluorescence intensity was close to that of the normal control group， and the localization at the cell membrane was significantly enhanced. Regarding autophagy-related indicators， the medium- and high- dose TUDCA groups significantly promoted autophagy activation， which was manifested as an increase in the LC3-Ⅱ/Ⅰ ratio， accelerated degradation of p62， and increased expression of Beclin-1. The results of cell apoptosis/necrosis detection showed that cell apoptosis/necrosis was significantly increased in the model group， while it was significantly alleviated after TUDCA intervention. Meanwhile， the expression of the anti - apoptotic protein Bcl-2 was up-regulated， and this ameliorative effect was most significant in the high- dose group. Conclusion TUDCA restores TBC1D15 membrane localization in a dose-dependent manner， subsequently activating the mitophagy pathway， and ultimately synergistically inhibits apoptosis/necrosis.

Key words: tauroursodeoxycholic acid, mitochondrial autophagy, TBC1D15, oxygen?glucose deprivation, cardiomyocyte injury

中图分类号:

R541

廖玮嫣,赵倩,陈泽屿,宣悦,熊胜涛,李东霖,王萧. 牛磺熊去氧胆酸通过调控TBC1D15改善线粒体自噬减轻氧糖剥夺心肌细胞损伤的机制[J]. 实用医学杂志, 2026, 42(2): 220-229.

Weiyan LIAO,Qian ZHAO,Zeyu CHEN,Yue XUAN,Shengtao XIONG,Donglin LI,Xiao WANG. Mechanism of tauroursodeoxycholic acid improving mitochondrial autophagy and alleviating oxygen-glucose deprivation myocardial cell injury by regulating TBC1D15[J]. The Journal of Practical Medicine, 2026, 42(2): 220-229.

图/表 8

图1

图2

图3

图4

图5

图6

表1

图7

参考文献 27

[1]	MANEECHOTE C， KERDPHOO S， JAIWONGKAM T， et al. Chronic pharmacological modulation of mitochondrial dynamics alleviates prediabetes-induced myocardial ischemia-reperfusion injury by preventing mitochondrial dysfunction and programmed apoptosis［J］. Cardiovasc Drugs Ther， 2023， 37（1）： 89-105. doi：10.1007/s10557-021-07250-7 . doi: 10.1007/s10557-021-07250-7
[2]	CHEN G， GAN J， WU F， et al. Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics［J］. Eur Heart J， 2025， 46（26）： 2579-2594. doi：10.1093/eurheartj/ehaf032 . doi: 10.1093/eurheartj/ehaf032
[3]	谢抗，李春，王勇，等. 芪参颗粒调控线粒体自噬干预炎症小体活化抗心肌细胞损伤的作用机制研究［J］. 中华中医药学刊， 2024， 42（12）： 35-39， 291-292. doi：10.13193/j.issn.1673-7717.2024.12.008 . doi: 10.13193/j.issn.1673-7717.2024.12.008
[4]	RABINOVICH-NIKITIN I， LOVE M， KIRSHENBAUM L A. Intersection of autophagy regulation and circadian rhythms in the heart［J］. Biochim Biophys Acta Mol Basis Dis， 2022， 1868（4）： 166354. doi：10.1016/j.bbadis.2022.166354 . doi: 10.1016/j.bbadis.2022.166354
[5]	SUN S， YU W， XU H， et al. TBC1D15-Drp1 interaction-mediated mitochondrial homeostasis confers cardioprotection against myocardial ischemia/reperfusion injury［J］. Metabolism， 2022， 134： 155239. doi：10.1016/j.metabol.2022.155239 . doi: 10.1016/j.metabol.2022.155239
[6]	LI F J， ABUDUREYIMU M， ZHANG Z H， et al. Inhibition of ER stress using tauroursodeoxycholic acid rescues obesity-evoked cardiac remodeling and contractile anomalies through regulation of ferroptosis［J］. Chem Biol Interact， 2024， 398： 111104. doi：10.1016/j.cbi.2024.111104 . doi: 10.1016/j.cbi.2024.111104
[7]	CHENG F， MA C， SUN L， et al. Synergistic neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells［J］. Exp Ther Med， 2018， 15（1）： 320-326. doi：10.3892/etm.2017.5395 . doi: 10.3892/etm.2017.5395
[8]	PEDRIALI G， RAMACCINI D， BOUHAMIDA E， et al. Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury［J］. Front Cell Dev Biol， 2022， 10： 1082095. doi：10.3389/fcell.2022.1082095 . doi: 10.3389/fcell.2022.1082095
[9]	LI Y Z， WU H， LIU D， et al. cFLIP（L） alleviates myocardial ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress［J］. Cardiovasc Drugs Ther， 2023， 37（2）： 225-238. doi：10.1007/s10557-021-07280-1 . doi: 10.1007/s10557-021-07280-1
[10]	LIU Y， LI L， WANG Z， et al. Myocardial ischemia-reperfusion injury； Molecular mechanisms and prevention［J］. Microvasc Res， 2023， 149： 104565. doi：10.1016/j.mvr.2023.104565 . doi: 10.1016/j.mvr.2023.104565
[11]	TÓTH A， LENTE G， CSIKI D M， et al. Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification［J］. Front Pharmacol， 2024， 15： 1399248. doi：10.3389/fphar.2024.1399248 . doi: 10.3389/fphar.2024.1399248
[12]	FU F， DOROUDGAR S. IRE1/XBP1 and endoplasmic reticulum signaling—From basic to translational research for cardiovascular disease［J］. Curr Opin Physiol， 2022， 28： 100552. doi：10.1016/j.cophys.2022.100552 . doi: 10.1016/j.cophys.2022.100552
[13]	BHATTACHARYA A， MUKHERJEE R， KUNCHA S K， et al. A lysosome membrane regeneration pathway depends on TBC1D15 and autophagic lysosomal reformation proteins［J］. Nat Cell Biol， 2023， 25（5）： 685-698. doi：10.1038/s41556-023-01125-9 . doi: 10.1038/s41556-023-01125-9
[14]	张华宇，殷思源，刘健，等. 氧糖剥夺条件下培养表皮干细胞的定量蛋白质组学分析［J］. 山东大学学报（医学版）， 2021， 59（4）： 17-27. doi：10.6040/j.issn.1671-7554.0.2021.0288 . doi: 10.6040/j.issn.1671-7554.0.2021.0288
[15]	ZHOU H， CHEN X， TAO Y， et al. Corticosterone-induced myocardial dysfunctions and the cardioprotective role of tauroursodeoxycholic acid： An experimental study in mice［J］. Clin Exp Pharmacol Physiol， 2025， 52（4）： e70027. doi：10.1111/1440-1681.70027 . doi: 10.1111/1440-1681.70027
[16]	LIU J Y， WANG Y， GUO Y， et al. Tauroursodeoxycholic acid targets HSP90 to promote protein homeostasis and extends healthy lifespan［J］. Sci China Life Sci， 2025， 68（2）： 416-430. doi：10.1007/s11427-024-2717-6 . doi: 10.1007/s11427-024-2717-6
[17]	YANG M， LINN B S， ZHANG Y， et al. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury［J］. Biochim Biophys Acta Mol Basis Dis， 2019， 1865（9）： 2293-2302. doi：10.1016/j.bbadis.2019.05.007 . doi: 10.1016/j.bbadis.2019.05.007
[18]	尹宝，谭向宇. LncRNA NEAT1通过miR-136/ERK1/2轴对改善心肌梗死大鼠心肌损伤的机制研究［J］. 中国免疫学杂志， 2025， 41（1）： 75-84. doi：10.3969/j.issn.1000-484X.2025.01.012 . doi: 10.3969/j.issn.1000-484X.2025.01.012
[19]	ZHOU T， MO J， XU W， et al. Mild hypothermia alleviates oxygen-glucose deprivation/reperfusion-induced apoptosis by inhibiting ROS generation， improving mitochondrial dysfunction and regulating DNA damage repair pathway in PC12 cells［J］. Apoptosis， 2023， 28（3-4）： 447-457. doi：10.1007/s10495-022-01799-w . doi: 10.1007/s10495-022-01799-w
[20]	韩雅茹，刘宇琳，赵苗，等. 抑制线粒体自噬在牛磺酸脱氧胆酸发挥心肌细胞保护中的作用及机制［J］. 中国新药杂志， 2019， 28（14）： 1744-1750.
[21]	YU T， VILLALONA P， KHAN S H， et al. Enhanced dynamic coupling in a nuclear receptor underlies ligand activity［J］. J Biol Chem， 2025， 301（2）： 108081. doi：10.1016/j.jbc.2024.108081 . doi: 10.1016/j.jbc.2024.108081
[22]	MIHAJLOVIĆ D， ĐUKANOVIĆ Đ， GAJIĆ BOJIĆ M， et al. Cardioprotective effects of ursodeoxycholic acid in isoprenaline-induced myocardial injury in rats［J］. Biomolecules， 2024， 14（10）： 1214. doi：10.3390/biom14101214 . doi: 10.3390/biom14101214
[23]	YU W， SUN S， XU H， et al. TBC1D15/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury［J］. Theranostics， 2020， 10（24）： 11244-11263. doi：10.7150/thno. 46883 . doi: 10.7150/thno. 46883
[24]	CHEN S， WANG H， CHEN J， et al. Upregulation of mitochondrial PGK1 by ROS-TBC1D15 pathway promotes neuronal death after oxygen-glucose deprivation/reoxygenation injury［J］. Brain Res， 2024， 1825： 148724. doi：10.1016/j.brainres.2023.148724 . doi: 10.1016/j.brainres.2023.148724
[25]	YU W， XU H， SUN Z， et al. TBC1D15 deficiency protects against doxorubicin cardiotoxicity via inhibiting DNA-PKcs cytosolic retention and DNA damage［J］. Acta Pharm Sin B， 2023， 13（12）： 4823-4839. doi：10.1016/j.apsb.2023.09.008 . doi: 10.1016/j.apsb.2023.09.008
[26]	CHANG Y， YANG T， DING H， et al. Tauroursodeoxycholic acid protects rat spinal cord neurons after mechanical injury through regulating neuronal autophagy［J］. Neurosci Lett， 2022， 776： 136578. doi：10.1016/j.neulet.2022.136578 . doi: 10.1016/j.neulet.2022.136578
[27]	HUANG X， YAO J， LIU L， et al. S-acylation of p62 promotes p62 droplet recruitment into autophagosomes in mammalian autophagy［J］. Mol Cell， 2023， 83（19）： 3485-3501.e11. doi：10.1016/j.molcel.2023.09.004 . doi: 10.1016/j.molcel.2023.09.004

组别	自噬溶酶体数量	自噬小体数量	合计数量
正常对照组	483	211	694
模型组	68	438	506
TUDCA 低剂量组（20 μmol/L）	166	447	613
TUDCA 中剂量组（40 μmol/L）	284	250	534
TUDCA 高剂量组（80 μmol/L）	379	114	493